KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Opko Health (OPK) Share-based Compensation (2016 - 2026)

Opko Health filings provide 17 years of Share-based Compensation readings, the most recent being $2.7 million for Q1 2026.

On a quarterly basis, Share-based Compensation rose 3.21% to $2.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.8 million, a 1.83% increase, with the full-year FY2025 number at $10.7 million, down 2.73% from a year prior.
Share-based Compensation hit $2.7 million in Q1 2026 for Opko Health, down from $2.9 million in the prior quarter.
In the past five years, Share-based Compensation ranged from a high of $7.6 million in Q1 2022 to a low of $2.2 million in Q2 2025.
Median Share-based Compensation over the past 5 years was $2.8 million (2023), compared with a mean of $3.2 million.
Biggest five-year swings in Share-based Compensation: skyrocketed 187.76% in 2022 and later plummeted 64.33% in 2023.
Opko Health's Share-based Compensation stood at $3.2 million in 2022, then dropped by 15.86% to $2.7 million in 2023, then grew by 3.7% to $2.8 million in 2024, then rose by 3.57% to $2.9 million in 2025, then dropped by 6.9% to $2.7 million in 2026.
The last three reported values for Share-based Compensation were $2.7 million (Q1 2026), $2.9 million (Q4 2025), and $3.0 million (Q3 2025) per Business Quant data.